CareFusion plans to buy Medegen for $225 million

04/5/2010 | Reuters

CareFusion agreed to pay $225 million to acquire Medegen, a maker of intravenous drug-delivery systems and needle-free access valves. CareFusion said the acquisition, which is expected to conclude by the end of June, is in line with its objective to purchase firms and technology that will boost its divisions including infusion and respiratory.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA